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ABSTRACT: NF-E2–related factor 2 (NRF2) transcription factor has a fundamental role in cell homeostasis mainte-
nance as one of the master regulators of oxidative and electrophilic stress responses. Previous studies have shown
that a regulatory connection exists between NRF2 and autophagy during reactive oxygen species–generated oxi-
dative stress. The aim of the present study was to investigate how autophagy is turned off during prolonged
oxidative stress, to avoidovereating anddestructionof essential cellular components.AMPKis akey cellular energy
sensorhighlyconserved ineukaryoticorganisms,and ithasanessential role inautophagyactivationatvariousstress
events. Here the role of human AMPK and its Caenorhabditis elegans counterpart AAK-2 was explored upon
oxidative stress. We investigated the regulatory connection between NRF2 and AMPK during oxidative stress
induced by tert-butyl hydroperoxide (TBHP) in HEK293T cells and C. elegans. Putative conserved NRF2/protein
skinhead-1 binding sites were found in AMPK/aak-2 genes by in silico analysis and were later confirmed experi-
mentally by using EMSA. After addition of TBHP, NRF2 and AMPK showed a quick activation; AMPK was later
down-regulated,however,whileNRF2 level remainedhigh.AutophagosomeformationandUnc-51–likeautophagy
activating kinase 1 phosphorylation were initially stimulated, but they returned to basal values after 4 h of TBHP
treatment. The silencingofNRF2 resulted in a constant activationofAMPKleading tohyperactivationof autophagy
during oxidative stress. We observed the same effects in C. elegans demonstrating the conservation of this self-
defensemechanism to save cells fromhyperactivated autophagyuponprolonged oxidative stress.We conclude that
NRF2 negatively regulates autophagy through delayed down-regulation of the expression of AMPK upon pro-
longed oxidative stress. This regulatory connection between NRF2 and AMPK may have an important role in
understanding how autophagy is regulated in chronic humanmorbidities characterized by oxidative stress, such as
neurodegenerative diseases, certain cancer types, and inmetabolic diseases.—Kosztelnik,M., Kurucz, A., Papp, D.,
Jones,E., Sigmond,T.,Barna, J., Traka,M.H., Lorincz,T.,Szarka,A.,Banhegyi,G.,Vellai, T.,Korcsmaros,T.,Kapuy,
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Oxidative stress is an inevitable and often disadvanta-
geous condition affecting essentially all living organisms.
It can arise from the imbalance of the antioxidant defense
mechanismsandthe reactiveoxygenspecies (ROS) suchas
hydroxyl •OH, superoxide O2
•–, and hydrogen peroxide
H2O2, and reactive nitrogen species such as nitric mon-
oxide •NO (1). These highly reactive molecules can be
produced endogenously (e.g., in mitochondria, peroxi-
some, cytosol) or generated due to exposure to numerous
exogenous agents (e.g., infrared, UV, cytokines, growth
factors, drugs, toxins, high temperature) (2). By taking
electrons from macromolecules, ROS can generate harm-
ful chemical processes leading to alteration anddamage of
cell structure, or even to cell death (3). If oxidative stress–
induced defense mechanisms are not sufficient, or the
stress is prolonged, it leads to many pathophysiologic
conditions (atherosclerosis, cancer, diabetes, cardiovascu-
lar diseases, chronic inflammation, stroke, and neurode-
generative diseases such as Parkinson’s or Alzheimer’s
disease) (4). If cells cannot recover by eliminating the
harmful effects of oxidative stress, programmed cell death
(i.e., apoptosis, necrosis, autophagic cell death) can occur to
maintain the functional integrity of the affected tissue (1).
The major transcriptional regulator of the antioxidant
stress response in animals isNF-E2–related factor 2 [NRF2
(NFE2L2)] (5, 6). NRF2 regulates the cellular antioxidant
response mechanism by modulating the expression of
hundreds of cytoprotective genes with antioxidant re-
sponse elements (AREs) in their promoters, including
antioxidant enzymes, phase II detoxifying enzymes, xe-
nobiotic transporters, and other stress response proteins
(5, 7). At physiologic conditions, NRF2 has some basal
level, but it is kept inactive by binding to a stoichiometric
inhibitor labeled Kelch-like ECH-associated protein 1
(KEAP1) and targeted for ubiquitination (8, 9). Various
oxidativeagentsresult inconformationalchangesofKEAP1,
thereby blocking NRF2 degradation. In Caenorhabditis ele-
gans, the NRF2 protein is represented by the 3 currently
known isoforms of the protein skinhead-1 (SKN-1).
Although NRF2 works as a dimer, SKN-1 binds to the
DNA in a unique monomeric form (5, 10). SKN-1 func-
tions similarly toNRF2 in response to oxidative stress and
is required for oxidative stress resistance and longevity in
C. elegans. NRF2 also up-regulates other processes, in-
cluding a cellular self-digesting pathway called auto-
phagy (11). During oxidative stress, autophagy is a key
element of cellular homeostasis that eliminates harmful
agents from the cytosol such as protein aggregates and
damaged mitochondria, and it thereby limits ROS pro-
duction and restores oxidative balance. It also has an
important role in guaranteeing the proper functions of the
cell by self-digesting the dispensable elements of the cell
during starvation. The focus of the present study was on
the regulation of themostwell-known type of autophagy,
namely (macro)autophagy (12).
The conjugated form of the microtubule-associated
protein 1A/1B-light chain 3 (LC3-II) is recruited to auto-
phagosomalmembranes, and theLC3-II level thusdirectly
estimates the abundance of autophagosomes before lyso-
somaldigestion. Because it reflects the autophagic activity,
detecting LC3-II levels is a reliable and well-characterized
method for monitoring autophagy flux and autophagy-
relatedprocesses (13). Thep62protein binds bothLC3 and
unfavorable proteins; therefore, p62-targeted proteins are
selectively transferred to the autophagosome and can be
removed by autophagy (14, 15). In the subsequent degra-
dation, both p62 and its substrate are destroyed; conse-
quently, the p62 level quickly drops during intensive
autophagy (16, 17). Blocking of autophagy results in an
increase in cellular p62 level, and this feature is therefore
used to detect dysfunctional autophagy (18, 19).
The induction of autophagosome formation is con-
trolled by the Unc-51–like autophagy activating kinase 1
(ULK1) complex, containing ULK1, ATG13, and FIP200
(20). ULK1 activity is tightly regulated by the nutrient and
energy sensors of cellular homeostasis, mammalian target
of rapamycin (mTOR), and AMPK, respectively (21). Be-
cause mTOR is fully active at physiologic conditions to
maintain general protein synthesis in the cell, mTOR is a
key negative regulator of the initial steps of autophagy
(22). However, AMPK becomes activated when the ATP:
ADP ratio is dropping, and it induces autophagy. AMPK
activation in turn inhibits mTOR, and AMPK can also in-
duce ULK1 activity directly (through phosphorylation of
Ser317, Ser555, and Ser777) (21, 23, 24).
The most relevant connection of autophagy and oxi-
dative stress response mechanism is achieved via NRF2.
Namely, activation of NRF2 occurs by the NRF2-
dependent transcription of the ubiquitin-binding and
autophagosome cargo protein p62. p62 quickly binds the
NRF2 inhibitor (KEAP1)uponoxidative stress, resulting in
the fast activation of the transcription factor (25). Recently,
active NRF2 was found to bind to the ARE sequence of
various autophagy regulators (e.g., Sqstm1/p62, ATG4,
ATG5, ATG7, Gabarapl1), suggesting that NRF2 has a
positive effect on autophagy (26). In addition, AMPK can
also stimulate NRF2 signaling upon oxidative stress (21,
27). AMPK directly phosphorylates NRF2 at Ser550, pro-
moting nuclear accumulation of NRF2 for ARE-mediated
gene transcription (28). AMPK also induces the anti-
oxidative heme oxygenase (HO-1) gene expression in hu-
man vascular cells and rat arteries via the NRF2/ARE
pathway (29). InC. elegans, metformin activates AAK-2 (the
wormorthologofAMPK) topromoteSKN-1/NRF2nuclear
translocation (30). Although several papers have shown the
importance of autophagy activation upon oxidative stress,
often viaNRF2 (reviewed in refs. 31–33), how autophagy is
down-regulated when oxidative stress is already balanced
to avoid overeating and destruction of further and essential
cellular components has not yet been explored.
Previously, genetic studies found that autophagy
down-regulation could indeed be beneficial upon pro-
longed oxidative stress, and, interestingly, this survival
mechanism involves NRF2. Anthocyanins from Chinese
bayberry extract, while activating NRF2 in b cells, were
found to negatively regulate oxidative stress–induced
autophagy, and this outcome provided a protective
effect after the transplantation of rat b cells under the
renal capsules of the recipient mice (34). In an-
other study, NRF2 was induced by an anticancer redox
agent, mitoquinone, and the direct involvement of
NRF2 in autophagy down-regulation was confirmed
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with genetic studies (35). Similarly, in mice, NRF2 de-
ficiency contributed to autophagy deregulation upon
age-related retinopathy, implying the importance of
NRF2 regulation of autophagy upon prolonged oxida-
tive stress (36). In cardiomyocytes exposed to pro-
longed oxidative stress, AMPK levels were found to
be decreased, resulting in autophagy inhibition (37).
Down-regulation of autophagy in these studies was not
detected when NRF2 activity was compromised, in-
dicating a direct role for NRF2 in autophagy inhibition.
Importantly, autophagydown-regulation in these studies
was not observed when oxidative stress was short term,
explaining why most of the previous oxidative stress–
related experiments focusing on NRF2 and autophagy
could not find this negative regulatory effect. To our
knowledge, none of the published works provided a
molecular mechanism for how NRF2 could down-
regulate autophagy. Identifying which genes and how
they are involved in the adaptation to prolonged oxida-
tive stress will contribute to our understanding of anti-
oxidant stress response and the pathogenesis of related
diseases, including cardiovascular disease and cancer, as
well as aging.
Prompted by these questions, in the present study we
investigated the relationship between NRF2 and auto-
phagy. Using computational regulatory network analysis,
we identified a conserved NRF2 binding site in the pro-
moter regionofAMPK.Wevalidated the functional role of
this binding site, and also the critical effect of NRF2 in
autophagy down-regulation, both in human cell lines and
in the model organism C. elegans. Our results uncovered
the mechanism of how NRF2 inhibits autophagy hyper-
activation upon prolonged oxidative stress.
MATERIALS AND METHODS
Cell culture and oxidative treatment
Humanembryonickidney (HEK293T)andhumancolonic (Caco-
2) cells were cultured in DMEM (41965039; Thermo Fisher Sci-
entific,Waltham,MA,USA) supplementedwith10%fetalbovine
serum (10500064; Thermo Fisher Scientific) and 1% antibiotics/
antimycotics (15240062; Thermo Fisher Scientific). This cell line
was maintained in adherent culture in a humidified incubator at
37°C in 95% air and 5% CO2. To simulate oxidative stress,
LuperosTBH70x, tert-butyl hydroperoxide (TBHP) solution
(458139; MilliporeSigma, Burlington, MA, USA) was used for
different lengths of time (i.e., 0.5, 1, 2, and 3 h).
Immunofluorescence
HEK293T cells (7 3 104) were seeded on glass coverslips (ECN
631–1577; VWR International, Radnor, PA, USA). Cells were
washed in PBS, fixed with ice-cold 100% methanol for 10 min,
andwashed again. Coverslips were blocked for 30minwith PBS
bufferwith 0.1%Tween-20 containing3%bovine serumalbumin
(A 9647; MilliporeSigma) and then incubated overnight at 4°C
with primary antibody (LC3 A/B, 4108S; Cell Signaling Tech-
nology,Danvers,MA,USA)at 1:200 dilution in 1%bovine serum
albumin containing PBS buffer with 0.1% Tween-20. Samples
were washed with PBS and then incubated for 1 h at room tem-
peraturewithAlexaFluor 488 (4412S;Cell SignalingTechnology)
secondary antibody at 1:600 dilution. Cells were washed with
PBS and treated with DAPI at 1:1000 dilution in PBS for 10 min,
followed by wash with PBS. Coverslips were mounted by using
FluorSave Reagent (345789; MilliporeSigma) and visualized by
using a Zeiss LSM 710 laser confocal microscope (Carl Zeiss
Microscopy GmbH, Jena, Germany). Three images per given
conditions were taken. All data are expressed as means 6 SEM.
Comparisons between groups were made by using ANOVA
with Tukey’s multiple comparison post hoc test. Statistical sig-
nificance was evaluated, and values of P, 0.05 were considered
significant.
Quantification of mRNA
Total RNAwas isolated fromHEK293T cells at 3 d of cultivation
by using Trizol reagent (Thermo Fisher Scientific). RNA was re-
verse transcribed by using the SuperScript II First-Strand Syn-
thesis System (Thermo Fisher Scientific). Quantification ofNRF2
and AMPKmRNAwas performed by using the GoTaq Quanti-
tative PCR (qPCR) Master Mix (A6001; Promega, Madison, WI,
USA). Forward and reverse primer sequences used for qPCR
were as follows: NRF2: 59-TCCAGTCAGAAACCAGTGGAT-
39and 59-GAATGTCTGCGCCAAAAGCTG-39; AMPK: 59-
ACTGTACCAGGTCATCAGTACACC-39and 59-TCCAGGTA-
CATCAGATTTCCTTC-39; and GAPDH: 59-TGCACCACCAA-
CTGCTTAGC-39 and 59-GGCATGGACTGTGGTCATGAG-39.
The PCR thermal program included the following: 10 min
at 95°C (1 cycle), and 30 s at 95°C, 45 s at 58°C, 30 s at 72°C (40
cycles), 5 min at 95°C, 1 min at 55°C, 30 s at 97°C (1 cycle).
Measures were performed on an Mx3005P qPCR System
(Stratagene, SanDiego, CA,USA).Melting curve analysiswas
performed to confirm correct PCRproduct size and absence of
nonspecific bands. RelativemRNA levelswere determined by
normalizing the PCR threshold cycle number of NRF2 and
AMPK with that of the GAPDH reference gene. Normalized
data were analyzed by using independent 2-sample Student’s
t tests with Bonferroni correction (SPSS v.20 software; IBM,
Armonk, NY, USA).
RNA interference in HEK293T cells
In the case of human cells, 1 d before the transfection, 2.5 3 105
HEK293T cells were plated in 2.5 ml growth medium without
antibiotics. Duplex RNA to targeting human NRF2 [sense
59-GGUUGAGACUACCAUGGUU(dTT)-39 antisense 59-AAC-
CAUGGUAGUCUCAACC(dTT)]-39was transfected into cells at
50–60% confluency. Small interfering RNA (siRNA) and Lipo-
fectamineRNAiMaxwerediluted intoOpti-MEMI (GlutaMax-I)
in accordance with the manufacturer’s protocol (Thermo Fisher
Scientific). siRNA duplex-Lipofectamine RNAiMax complexes
were added to each well. Cells were assessed at 24 h after
transfection by using real-time PCR. For negative control
scramble, siRNA was used.
Western blot analysis
Treated HEK293T or Caco-2 cells were collected and lysed by
using RIPA buffer (20 mMTris, 135 mMNaCl, 10% glycerol, 1%
NP40, pH 6.8). Protein concentrations were measured by using
Pierce BCA Protein Assay (Thermo Fisher Scientific, 23225).
Equal amounts of protein were separated on a 10–15% SDS-
PAGE gel and transferred to PVDF membrane (0.45; Milli-
poreSigma). Membranes were blocked with 5% nonfat dry milk
or 1%bovine serumalbumin in Tris-buffered saline, 0.1%Tween
for 1 h followed by overnight incubation at 4°C with primary
antibodies in 1%milkor 1%bovine serumalbumin.Theantibody
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sources are as follows: phospho-AMPKa Thr172 (2531S; Cell
Signaling Technology), AMPKa (23A3; Cell Signaling Technol-
ogy), NAD(P)H:quinone oxidoreductase 1 (NQO1) (A180; Cell
Signaling Technology), anti-LC3b (sc-16755; Santa Cruz Bio-
technology, Dallas, TX, USA), 4EBP1P (9459S; Cell Signaling
Technology), phospho-ULK1 Ser555 (5869S; Cell Signaling
Technology), ULK1 (8054S; Cell Signaling Technology),
anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(sc-32233; Santa Cruz Biotechnology), HO-1 (D60G11; Cell
Signaling Technology), NRF2 (C15410242; Diagenode, Den-
ville, NJ, USA), and horseradish peroxidase conjugated sec-
ondary antibodies (sc-2020, sc-2005, SantaCruzBiotechnology;
7074S, 7076S, Cell Signaling Technology). To detect both the
phosphorylated and total forms of the same proteins, equal
amounts of samples were blotted onto different PVDF mem-
branes. Cross-reactivity and protein removal problems were
avoided byusing this approach. Each experimentwas repeated
3 times. The quantification of Western blot bands was con-
ducted on ImageQuant 5.2 software (GEHealthcareLife Sciences,
Little Chalfont, United Kingdom). Relative band densities were
normalized to appropriate total protein or GAPDH used as ref-
erence protein. The average of 3 independent measurements was
calculated. All data are expressed as means6 SEM. Comparisons
between groups were made by using ANOVA with Tukey’s
multiple comparison post hoc test. Statistical significance was
evaluated, and values of P, 0.05 were considered significant.
Measurement of oxidative stress by
flow cytometry
HEK cells were seeded on 6-well plates and treated as indi-
cated. After treatment, cells were trypsinized, washed once
with PBS, and 0.5 3 106 cells/ml were labeled with 10 mM
dichlorofluorescein-diacetate (DCF) or 2mMBodipy-[11C] (BOD)
for 30min inHBSSat 37°C.After labeling, cellswerewashedonce
with PBS, resuspended in PBS, and analyzed with a BD FACS-
Calibur flow cytometer (BD Biosciences, Franklin Lakes, NJ,
USA). The fluorescence of DCF and BOD from excitation with a
488 nm laser was recorded in FL1 (530 nm). Cell population was
gated through the SSC-FSC scatter plot by using unlabeled cells,
and histograms normalized to the samples’ mode were con-
structedbyusingFlowJosoftware (FlowJo,Ashland,OR,USA).A
minimum of 10,000 cells were analyzed per condition.
Nuclear extracts and 2-color fluorescence EMSA
Nuclear extracts were prepared from Caco-2 cells treated with
100 mMTBHP for 4 h, using the Nuclear Extraction Kit (Abcam,
Cambridge, MA, USA) according to the manufacturer’s instruc-
tions. Single-stranded oligonucleotide probes containing either
AMPK query Nrf2 binding site (59-AAACCATGACTCTGCA-
TAAAA-39 and 59-GATCTTTTATGCNNNGTCAATG-39) or
AMPK NRF2 consensus binding site (59-GATCTTTTATGC-
TGTGTCATGG-39 and 59-AAACCATGACACAGCATAAAA-
39) were manufactured by Integrated DNA Technologies
(Coralville, IA, USA) and annealed at 95°C for 5 min, then
cooled slowly to room temperature for several hours. Gel shift
analysiswas conductedbyusing theEMSAkitwithSYBRGreen
and SYPRO Ruby (Thermo Fisher Scientific) according to the
manufacturer’s instructions. Briefly, binding reactions were
performed in a total volume of 10 ml containing 5 mg of nuclear
extract, 1 ng of DNAprobe, and 5 times binding buffer (750mM
KCl, 0.5mMDTT, 0.5mMEDTA, 50mMTris, pH7.4) for 20min
at room temperature. In supershift experiments, nuclear extracts
were preincubatedwith 2mg of anti-Nrf2 antibody (sc365949-X;
Santa Cruz Biotechnology) for 30 min before the addition of the
oligonucleotide probe. At the end of the incubation period,
63 gel-loading solution was added to the binding reaction and
protein–probe complexes separated by electrophoresis on a
nondenaturing Novex 4–20% Tris-Glycine Mini Gel (Thermo
FisherScientific) at 100V for 2hat 4°C.Tovisualizenucleic acids,
the gel was stained with SYBR Green EMSA gel stain in TBE
buffer (89 mM Tris base, 89 mM boric acid, 1 mM EDTA, pH
;8.0), washed in dH2O, and imaged by using the AlphaImager
system (ProteinSimple, San Jose, CA, USA). Proteins were sub-
sequently visualized on the same gel by using SYPRO Ruby
EMSA gel stain. After washing in dH2O, proteins were imaged
byusing theAlphaImager system.Gel bandswerequantified by
using the ImageJ/Fiji software package (National Institutes of
Health, Bethesda, MD, USA).
C. elegans strains and maintenance
Unless otherwise indicated, nematodes were maintained and
propagated at 20°C on nematode growth medium (NGM)-
containing plates and fed with Escherichia coli OP50 bacteria.
Experiments were performed at 20°C on young adult her-
maphrodites. The following C. elegans strains were used in this
study: Bristol (N2) as wild-type, BU071 green flurescent pro-
tein (GFP)::LGG-1, TG38 aak-2(gt33), atg-11(tm2508), EU31 skn-
1(zu135) IV/nT1 [unc-?(n754) let-?] (IV;V) [zu135 allele is a
nonsense mutation that prevents DNA binding by all 3 SKN-1
isoforms (38)], skn-1(lax120), TTV453 aak-2::gfp;skn-1(zu135),
GFP::LGG-1;aak-2(gt33). The translational fusion aak-2::gfp re-
porter strain was a kind gift of Hyeon-Sook Koo (39).
RNA interference treatment in C. elegans
skn-1 was silenced by feeding C. elegans with E. coli HT115 bac-
teria that expressed skn-1 double-stranded RNA from the vector
pL4440. The skn-1RNA interference (RNAi) bacteriawere a kind
gift of T. Keith Blackwell (40). Overnight culture of skn-1 RNAi
bacteria were seeded onto NGM plates containing 50 mg/ml
ampicillin, 6.25 mg/ml tetracycline, and 0.4 mM isopropyl
b-D-thiogalactoside (R0393; Thermo Fisher Scientific) in final
concentration. Worms were grown on RNAi bacteria from
hatching until the L4/young adult stage. Empty vector contain-
ing HT115 bacteria was used as a control in the assays.
Oxidative stress (paralysis) assay in C. elegans
Twenty to thirty age-synchronized young adult worms were
transferred onto NGM or RNAi plates, respectively, containing
10 mM TBHP (A13926; Alfa Aesar, Ward Hill, MA, USA). All
TBHP plates were prepared 1 d before the assays. Mobile and
paralyzed animals were counted in every hour. Animals were
countedasparalyzed if they failed tomoveuponproddingwitha
wormpick.At least 15wormswere assayed in all conditions, and
the experiments were repeated 3 times. All experiments were
conducted at 20°C. Statistical significance was determined by
using independent 2-sample Student’s t tests.
Fluorescent microscopy
For fluorescent microscopy, young adult worms were immobi-
lized by using 0.1 M levamisole or 10 mM NaN3 in M9 buffer.
Images for quantitative analysis were taken by using an Olym-
pus BX51microscope (Shinjuku, Tokyo, Japan), Leica DMI6000B
microscope (Leica Camera AG, Wetzlar, Germany), or Zeiss
AxioImager Z1. To observe AAK-2::GFP expression upon oxi-
dative stress, age-synchronized L4 larvae were transferred to
TBHPassayplates containing1, 2, or 4mMTBHP;NGMorRNAi
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plates without TBHP were used as control. Images of whole
animalswere taken after 1, 5, or 24 h incubation, and fluorescence
intensity was measured by using ImageJ software. At least 15
worms were analyzed in all conditions, and the experiments
were repeatedat least 3 times.TostudyGFP::LGG-1punctaupon
oxidative stress, young adult age-synchronized worms were in-
cubated on TBHP assay plates (1 mM TBHP) for 3 h. Epifluor-
escence images of thewhole animals and the first 2 intestinal cells
behind the pharynx were taken and analyzed by using ImageJ
software; the GFP::LGG-1 positive area were measured relative
to the area of the cell on each image. Up to 36 worms were ana-
lyzed in all conditions, and the experiments were repeated 2
times. All experiments were conducted at 20°C. Statistical sig-
nificance was determined by using independent 2-sample Stu-
dent’s t tests.
RESULTS
Putative conserved NRF2/SKN-1 binding sites
were found in AMPK/aak-2 genes
Previously, we developed an online resource, NRF2ome
(http://nrf2.elte.hu/), which provides an integrated and
systems-level database for NRF2 (6, 41). NRF2ome con-
tains experimentally verified and predicted interactions of
NRF2, and it lists known and potential NRF2 target
genes, NRF2-regulating transcriptional factors, and
microRNAs (41). We also developed the Autophagy
Regulatory Network database (http://arn.elte.hu/) that
contains autophagy components (proteins involved in
the mechanisms of autophagy), their regulators, and
their transcription factors (42). Comparing NRF2 target
genes from NRF2ome with autophagy genes from the
Autophagy Regulatory Network database, we found sev-
eral autophagy-related genes that contain NRF2/ARE–
binding sites (GCNNNGTCA) (43) in their promoter or
coding region.We focused on theAMPKgene, becauseHe
et al. (37) had showed earlier that prolonged oxidative
stress can attenuate adaptive AMPK signaling and in-
hibit autophagy. We uncovered consensus NRF2 bind-
ing sites in both the promoter region and the first intron
of the human AMPK gene. One putative binding site is
located 100 bpupstreamand the other 2.2 kbdownstream
of the ATG translational initiation site. We hypothesized
that during oxidative stress, possible NRF2-dependent
suppression of autophagy by down-regulating the
AMPK signaling pathway may be a strategy to control
cell survival.
The canonical NRF2/ARE binding sites are present in
the proximity of AMPK genes of other vertebrate and in-
vertebrate species, including C. elegans (Fig. 1A, B). Our
genome-wide sequence analysis identified 3 canonical
SKN-1 (NRF2 ortholog) binding sites (WWTRTCAT,
where R = A or G) in the regulatory and coding regions of
theC. elegans aak-2gene (wormortholog ofAMPK), 100 bp
upstream and 1073 and 1573 bp downstream of the ATG
translational initiation site, respectively. These sites are
also highly conserved in the aak-2 genomic region of
closely related Caenorhabditis species (Fig. 1A). Next, we
compared these in silico predicted SKN-1 binding sites
with the experimentally identified regulatory elements
found in the relevant analysis of the model organism
Encyclopedia of DNA Elements (modENCODE) project
(44). According to a chromatin immunoprecipitation and
multiplex sequencinganalysis (Brdlik et al.)(44), the second
binding site of SKN-1 seemsmost likely to be functional, as
SKN-1 proteinwas found to bind to this region of the aak-2
gene in every larval stage tested (L1–L4) (Fig. 1C). SKN-1
was also found to bind to the promoter region of aak-2 but
not at every larval stage. These results suggest that these
ARE sites might be functional and that the second poten-
tial binding site is most likely to be an actual ARE. These
data, together with the presence of conserved NRF2/
SKN-1 binding sites in the AMPK/aak-2 locus, raise the
possibility that putative molecular interactions between
Figure 1. Putative conserved NRF2/SKN-1 binding sites were found in aak-2/AMPK genes. A) Location and sequences of the
conserved putative NRF2/SKN-1 transcription factor binding sites, relative to the transcription start site (+1) in different species.
(N denotes arbitrary nucleotides, R indicates adenine or guanine, and S indicates cytosine or guanine.) B) The genomic region
of AMPK and aak-2 gene with predicted NRF2 and SKN-1 binding sites. Black boxes correspond to exonic sequences; connecting
lines represent introns. Red triangles indicate conserved NRF2/SKN-1 binding sites. C) The genomic region of the aak-2 gene
with 2 possible SKN-1 binding sites. The blue lines indicate the genomic regions where Brdlik et al. (44) identified binding sites
for SKN-1 in their chromatin immunoprecipitation and multiplex sequencing (ChIP-Seq) assay in any of the 4 larval stages of C.
elegans. Black boxes correspond to exons; connecting lines represent introns. Red triangles indicate conserved SKN-1 binding
sites. TSS indicates the transcription start site. L1, 2, 3, and 4 are the 4 larval stages of C. elegans before reaching adulthood.
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NRF2/SKN-1 and AMPK/aak-2 are evolutionarily con-
served from worms to humans.
NRF2 represses AMPK expression
To analyze the regulatory effect of NRF2 on AMPK
expression during oxidative stress, relative levels of
both AMPK and NRF2 mRNA were measured with
qPCR under oxidative stress–induced circumstances.
We established a protocol to induce oxidative stress in
HEK293T cells by using the organic peroxide TBHP.
TBHP is a widely used agent that results in oxidation of
reduced glutathione, peroxidation of cellular lipids, and
altered Ca2+ homeostasis, which leads to cell death (45).
The oxidizing effect of TBHP was verified by using flow
cytometry (Supplemental Fig. S1). TBHP induced ROS
production and lipid peroxidation (see the table and his-
togram red line: 300 mM TBHP on Supplemental Fig. S1)
as opposed to untreated cells (table and histogram black
line with gray background on Supplemental Fig. S1) as
measured by increased DCF and BOD fluorescence, re-
spectively. Silencing of NRF2 through attenuated both
TBHP-induced ROS production and lipid peroxidation
(table and histogram green line: 300 mM TBHP + NFkB
siRNA on Supplemental Fig. S1), but an oxidative envi-
ronment was observed.
Generating oxidative stress by adding various concen-
trations of TBHP clarified that 1.5 h of treatment with
100 mM TBHP was able to increase the level of NRF2
mRNA, whereas addition of 300 mM TBHP resulted in a
slight decrease in the NRF2 mRNA level in control cells
(Fig. 2andSupplemental Fig. S2).Due to the fact thatNRF2
ismainly controlledat theposttranscriptional level,wealso
analyzedNRF2 activity on the protein level. In addition to
immunoblotting NRF2, two well-known NRF2 targets,
NQO1 (46) and HO-1 (47), were used to follow the time-
dependentactivationofNRF2onaprotein level.Therefore,
we chose 100 mM TBHP treatment to focus on the time
dependency of oxidative stress in HEK293T.
We found that the effect of TBHP treatment on AMPK
and NRF2 mRNA levels occurs in a time-dependent
manner (Fig. 2A). The longer the cells were treated with
TBHP, themoreNRF2and lessAMPKmRNAwerepresent
in cells. In cells growing for 1, 2, 3, or 4 h in 100 mM final
concentration, TBHPmediumwas significantly lessAMPK
(at 4 h, only 41%mRNA relative to control cells) andmore
NRF2mRNA (at 4 h 194%mRNA relative to control cells).
These qPCR analysis results suggest that oxidative stress
lowers the transcription of AMPKwith a certain time de-
lay while quickly enhancing the transcription of NRF2.
Interestingly, the AMPK mRNA level did not show any
decrease when TBHP treatment was preceded by using
siRNA to silence NRF2. The fact that lowering of AMPK
mRNA levels requires NRF2 suggests a regulatory in-
teraction between the AMPK gene and NRF2 protein.
Toverify the relationshipbetweenAMPKandoxidative
stress, the expression level of total AMPK proteins was
analyzed by using Western blot in HEK293T cells. Time
dependency was clearly shown in AMPK levels because
they were elevated (from 4 to 9 times) in each sample
treated with TBHP (1–4 h) relative to the control samples
(Fig. 2B, C and Supplemental Table S1). Both AMPK
phosphorylation and its total protein level showed a
transient peak during TBHP treatment, and this activation
profile is correlated to NRF2, NQO1, and HO-1 level
supposing that NRF2 might have some regulatory role in
AMPK. The densitometry data of AMPK protein level
normalized for GAPDH directly show us that the AMPK
protein level was also decreased after 3 h of TBHP treat-
ment. It is well known that the half-life of AMPK is rela-
tively long; therefore, the AMPK protein level could
remain high much longer compared with the AMPK
mRNAlevelduringpermanentoxidativestress. To further
analyze the effect of NRF2 on AMPK during oxidative
stress, Western blot experiments were also performed
whenNRF2was silenced by using siRNA.NRF2 silencing
was detected by depletion of NRF2, NQO1, and HO-1
protein levels. Relative to control cells, AMPK levels were
significantly increased in cells treated with siNRF2. In
these cells, AMPK protein levels were not suppressed;
however, a 7 timeshigherbasicAMPKlevelwaspresent in
control and treated cells relative to theunsilenced samples.
These data suppose that oxidative stress–inducedNRF2 is
able to suppress human AMPK levels in both a time- and
dose-dependent manner.
NRF2 directly binds to the ARE binding site
at AMPK
ToassesswhetherNRF2 is able to bind to its potentialARE
sequence in the promoter region of AMPK (query se-
quence), an EMSA study was performed with nuclear
extracts isolated from Caco-2 cells treated with TBHP for
4 h.We used thewell-known, consensus ARE sequence as
a positive control. Assembly of the NRF2 protein–probe
complex was visualized by using a 2-color fluorescence
staining technique to observe both the nucleic acid and the
protein components of the assay (48). As shown in Fig. 3A,
the gel shift assay identified protein–probe complex for-
mation in the presence of either AMPK query (lane 5) or
consensus (lane 4) oligonucleotides, compared with no
complex formation in control lanes containing oligonu-
cleotide probe (lanes 1–2) or nuclear extract only (lane 3).
Supershift assays using a specific anti-NRF2 antibody
showed a 11 and 10.5% decrease in the protein–probe
complex formation for both the AMPK query and the
consensus oligonucleotide probes, respectively (Fig. 3B),
indicating the presence of NRF2 in the protein–probe
complex. Although no retarded NRF2 complex was
identified, ithasbeenshownthatbindingof theantibody to
NRF2protein can reduce its oligonucleotideprobe-binding
capacity (49). These results indicate NRF2 binds to both
AMPK query and consensus oligonucleotide sequences.
NRF2 negatively regulates prolonged
autophagy via AMPK
To address the impact of oxidative stress and NRF2 on
autophagy, we also analyzed the time dependency of
certain key autophagy markers in TBHP treatment by
immunoblotting in HEK293T cells (Fig. 4). To detect
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Figure 2. NRF2 down-regulates both mRNA and protein levels of AMPK in the HEK293T cell line after long exposure to oxidative
stress. A) Time dependency of both NRF2 and AMPK mRNA levels in oxidative stress with/without silencing of NRF2 by siRNA.
HEK293T cells were treated with 100 mM TBHP. The relative level of mRNA was measured by quantitative real-time PCR. Nrf2
gene expression was depleted by Nrf2 siRNA. TBHP-treated samples were compared with control (Ctrl) samples. B) Time
dependency of total AMPK protein levels (AMPK-T), NRF2, NQO1, and HO-1 during oxidative stress. Cells were treated with
100 mM TBHP, while the AMPK level was detected by immunoblotting. Nrf2 gene expression was depleted by Nrf2 siRNA.
GAPDH was used as a loading control. C) Quantification and statistical analysis of Western blot assays. Densitometry data
represent the intensity of AMPK-T, NRF2, NQO1, and HO-1 normalized for GAPDH. Samples were compared with their partner
with siNRF2 background. Error bars represent 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.005 (independent 2-sample Student’s
t tests).
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whether AMPK is activated upon oxidative stress, the
level of active, phosphorylated AMPK was measured.
Because not only does the level of p-AMPKAalpha
change upon oxidative stress but AMPKAalpha is also
up-regulated, on Fig. 4Bwe show the time profile of p-
AMPKAalpha/GAPDH during oxidative stress. We
also analyzed the phosphorylation status of its direct
target, ULK1. Phosphorylated Ser555 onULK1 assumes
an activated autophagy process induced by phospho-
AMPK. Interestingly, we found a transient activation
for AMPK upon prolonged oxidative stress. Both
AMPK andULK555were fully phosphorylated after 1 h
of TBHP treatment, suggesting an essential role of
AMPK in autophagy induction. However, AMPK
activity later quickly dropped (as indicated by its
dephosphorylation after 3 h of TBHP treatment),
suggesting a delayed negative feedback on AMPK ac-
tivity during oxidative stress. Some key autophagy
markers (e.g., LC3, p62) also indicated that auto-
phagy exhibits an activation peak during oxidative
stress, but long treatment with an oxidative agent sup-
presses autophagy. To confirm that this time profile of
autophagy activation occurs in an NRF2-dependent
manner, the experiment was repeated in NRF2-silenced
HEK293T cells. Remarkably, both AMPK-P and ULK555P
were increased in NRF2-silenced control cells. Further-
more, levels of each autophagy markers we used (AMPK-
P, ULK555P, and LC3-II) remained high, whereas the
autophagy substrate p62 was robustly reduced after 4 h of
TBHP treatment in cells pretreated with NRF2 siRNA.
These results confirm that NRF2 negatively regulates
autophagy via AMPK.
Densitometry data of autophagy markers (i.e., LC3-II/
LC3I, p62, ULK555) show that autophagy has a transient
activity change during oxidative stress (Fig. 4B). To verify
the delayed negative effect of NRF2 on autophagy with
respect to permanent oxidative stress, autophagy was
analyzed by using immunofluorescence microscopy
(LC3 ICC staining) with and without NRF2 silencing
(Fig. 5). To generate oxidative stress, TBHPwas added to
HEK293T cells for several hours prior to with/without
NRF2 siRNA treatment. Cells were fixed and immuno-
labeled for endogenous LC3-I/II (green). Thus, LC3-I
shows diffused cytoplasmic staining, and LC3-II can be
observed in discrete foci. As positive controls, bafilo-
mycin A1 and rapamycin were used. Although bafilo-
mycin A1 is a well-known inhibitor of the late phase of
autophagy resulting in the latent accumulation of auto-
phagosomes, rapamycin hyperactivates autophagy via
mTOR inhibition (50–53). We detected a 5-fold increase
in the relative amount of autophagosomes in control cells
treated with TBHP; however, after 4 h of treatment, the
amount of autophagosomes was similar to the basal
level. In contrast, the relative amount of autophago-
somes remained significantly high both in the absence of
NRF2 under control conditions and during excessive
levels of TBHP. These results fit to the Western blot
analysis and confirm at the cellular level that transient
autophagy is down-regulated by NRF2 upon prolonged
oxidative stress (Supplemental Fig. S3).
In vivo evidence for the relationship of aak-2
and SKN-1
As a model organism, C. elegans provides several charac-
teristics that can confirm our in vitro/in silico and cellular
models. The conservation of disease/signaling pathways
betweenC. elegans and higher organismsmakes theworm
an effective in vivo model. We used an aak-2::gfp reporter
strain (39) and tested how its expression is changed in
Figure 3. NRF2 binds to AMPK query and consensus
oligonucleotide sequences. Nuclear extracts (NE) of Caco-2
treated with TBHP were incubated with query (Q) (lane 4) or
consensus (C) (lane 5) oligonucleotide probes and compared
with nuclear extract only control (lane 1). Image of the EMSA
gel stained with SYBR Green EMSA stain identified nucleic
acids (green), and subsequent SYPRO Ruby EMSA stain
identified protein (red) components. NRF2 protein–probe
complexes (yellow) formed only in lanes containing nuclear
extracts + probe. B) Caco-2 nuclear extracts were incubated
with 2 mg of anti-NRF2 antibody (Ab.) before the addition of
oligonucleotide probe (lanes 3 and 5) and analyzed for
complex retardation.
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response to oxidative stress. The translational fusion re-
porter construct contains thewhole genomic region of aak-
2 gene and the 2 kb upstream promoter region (Fig. 6A).
Broad GFP expression was observed in the pharynx, gut,
and nervous and reproduction systems of the young adult
animals. The reporter was up-regulated in skn-1(2) null
mutants (P , 0.005) (Fig. 6B), as well as in skn-1 RNAi-
treated animals (P , 0.0001) (Supplemental Fig. S4). The
Figure 4. NRF2 down-regulates
autophagy proteins after long
exposure to oxidative stress in
the HEK293T cell line. A) Time
dependency of autophagy down-
regulation by NRF2 in oxidative
stress. Western blot results of
HEK293T cells in 100 mM TBHP-
containing media. The Western
blot shows the time course levels
of autophagy-related proteins.
Cells were cultured with TBHP
for 0.5, 1, 2, 3, and 4 h, while
NRF2 gene expression was de-
pleted by NRF2 siRNA. GAPDH
was used as a loading control.
B) Quantification and statistical
analysis of the Western blot assays.
Densitometry data represent the
intensity of p62 normalized for
GAPDH, LC3-II normalized for
LC3-I, ULK555-P normalized
for total level of ULK, and
AMPK-P normalized for GAPDH.
Samples were compared with their
partner with siNRF2 background.
Error bars represent 6 SEM. *P ,
0.05, **P , 0.01, ***P , 0.005
(independent 2-sample Student’s
t tests).
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mostapparent/strikingdifferences regarding the intensity
of fluorescencewere observed in the head and pharynx of
the animals. In acute oxidative stress (5 h), the aak-2::gfp
expression was decreased (P, 0.0001), but this reduction
in fluorescence disappeared when the skn-1 gene was si-
lenced (Fig. 6C). The inhibition of aak-2::gfp expression
by oxidative stress was dose dependent: we observed
the maximal inhibition at 2 mM TBHP concentration
(Supplemental Fig. S5 and Supplemental Table S2).
However, this decrease of aak-2::gfp expression was
suppressed when worms were maintained on TBHP-
containing plates for 24 h (Fig. 6D). Altogether, these
results provide in vivo evidence for the time- and dose-
dependent relationship of aak-2 expression, oxidative
stress, and SKN-1.
To test the role and the position of aak-2 and skn-1 in
oxidative stress response, we measured the oxidative re-
sistance of skn-1 RNAi-treated and/or aak-2 and skn-1
mutant worms. In response to higher level of oxidative
stress (10 mM TBHP), C. elegans displays loss of motility
andprogressiveparalysis.WithoutSKN-1, thisparalysis is
more definite after 7 h (76% of paralyzed animals in wild
type vs. 85% in SKN-1 depleted animals) (Fig. 6E and
Supplemental Table S3). Eleven percent of the aak-2(gt33)
deletionmutant animalswereparalyzedafter 7h,whereas
76% of the N2 animals lost their motility. Without SKN-1,
Figure 5. NRF2 silencing positively regulates autophagy. The connection of NRF2-dependent oxidative stress and autophagy
induction was checked by immunofluorescence microscopy. LC3 was stained by green fluorescence dye (Alexa Fluor 488);
therefore, the green dots in the cells represent functional autophagosomes. A) Time dependency of TBHP-induced (100 mM)
autophagy regulation by NRF2. Rapamycin (Rap, 100 nM, 2 h) and bafilomycin (Baf, 10 mM, 2 h) were used as positive controls.
B) Quantification and statistical analysis of immunofluorescence microscopy data. Error bars represent6 SEM. **P, 0.01, ***P, 0.005
(independent 2-sample Student’s t tests).
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this difference was smaller (N2 vs. aak-2(gt33): 85 vs. 23%).
Most of the skn-1(lax120) gain-of-function mutant animals
remained mobile even after 7 h, but this resistance to oxi-
dative stress was suppressed in skn-1 silenced animals.
skn-1 gain-of-functionmutants displayed TBHP resistance
reminiscent of aak-2 loss-of-functionmutants. Thus, SKN-1
is likely to promote TBHP resistance by negatively regu-
lating aak-2 activity.
In C. elegans, tagging LGG-1 (worm ortholog of Atg8/
LC3) with a fluorophore has become a widely accepted
method to visualize autophagosomes (54, 55). The quan-
titative assessment of the fluorescence signal of cells with
numerous LC3-positive puncta can be assessed accurately
at a single-cell level (56). GFP::LGG-1 is expressed
throughout development in multiple tissues and dis-
plays a diffuse expression pattern, whereas under con-
ditions that induce autophagy,GFP::LGG-1 labels positive
punctate structures, and its overall expression increases in
multiple tissues, including intestinal cells. The amount of
GFP::LGG-1–positive vesicles correlates with the forma-
tion of autophagosomes, making GFP::LGG-1 an accept-
able marker for detecting autophagosomes. Thus, we
could test whether AAK-2 or SKN-1 is required for
autophagy by monitoring changes in the number of
GFP-positive structures or the ratio of GFP-positive
area (autophagosomes) in the cells of transgenic ani-
mals (57, 58).
To further analyze the possible relationship between
oxidative stress, SKN-1, AAK-2, and autophagy, we also
measured relative autophagy activity in aak-2 mutant
worms. We incubated the young adult animals on plates
containing1mMTBHP for 3hwith orwithout skn-1RNAi
treatment, using an integrated GFP-tagged LGG-1 re-
porter strain our group generated earlier (59). There was
no significant autophagy activity difference in the control
RNAi N2 and aak-2 mutant animals without TBHP treat-
ment. Upon oxidative stress, the area of GFP::LGG-1–
positive loci decreased drastically by 80% (Fig. 7A, B and
Supplemental Table S4) inwild-type animals (P, 0.0001).
In aak-2(gt33)mutantworms, however, this reductionwas
not as definite [only 40% (P, 0.0001)]. This findingmeans
that inanimals lacking functionalAAK-2protein, theeffect
of oxidative stress on autophagy is suppressed. If skn-1
gene expression is depleted, autophagy decreased by 33%
(P,0.0001) in the cells of thewild-typeanimals.However,
in TBHP-treated aak-2 mutants, the ratio of GFP-positive
Figure 6. SKN-1/NRF2 down-regulates aak-2/AMPK expression upon oxidative stress in C. elegans. A) The genomic region of aak-2
with predicted SKN-1 binding sites, and the structure of the translational aak-2::gfp reporter gene, is shown. Black boxes
correspond to exonic sequences, connecting lines represent introns. Red triangles indicate conserved SKN-1 binding sites. B)
Expression of aak-2::gfp transgene was increased in skn-1(-) mutant background. C) In acute oxidative conditions (2 mM TBHP, 5
h), aak-2::gfp expression was decreased in animals with wild-type background. The absence of skn-1 gene products eliminated this
change of gene expression. D) In chronic oxidative conditions (2 mM TBHP, 24 h), aak-2::gfp gene expression was not inhibited.
E) Paralysis assay of worms held on 10 mM final concentration TBHP plates. Data are expressed as the ratio of paralyzed/
nonparalyzed worms. The number of animals examined: n = 15–100. Error bars represent 6 SEM. All experiments were
independently reproduced 3 times. *P , 0.05, ***P , 0.005 (independent 2-sample Student’s t tests).
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area of autophagosomes did not decrease as much as in
wild-type animals (76 vs. 58% reduction in TBHP treated
N2 vs. aak-2(gt33) worms, respectively) (Fig. 7B and Sup-
plemental Table S4). According to this result, in the pres-
ence of the aak-2 mutation, autophagy is more active
duringoxidative stress.Oxidative stress lowers the level of
autophagy both inwild-type and in aak-2mutant animals,
but this effect is smaller if the skn-1 gene is silenced.
We also examined the resistance/tolerance of auto-
phagy deficiency upon oxidative stress by using atg-11
mutant nematodes [tm2508 allele containing a 548 bp de-
letion (atg-11 has a role in the initiation of autophagosome
formation)]. After 7 h of 10 mM TBHP treatment, 76% of
the wild-type animals became paralyzed (Fig. 7C and
Supplemental Table S5), whereas only 16% of autophagy
mutant atg-11 animals exhibited a paralyzed phenotype.
Thus, the stress resistance/tolerance of the autophagy-
deficient mutant animals is better than the wild-type’s
during oxidative stress, indicating that autophagy could
not be beneficial upon long-term oxidative stress. The
presence or absence of skn-1 gene products changed this
ratio only in the atg-11mutant animals. With these in vivo
experiments, we confirmed that the effect of SKN-1 on
autophagy occurs through the inhibition of aak-2 expres-
sion, showing that this down-regulatory mechanism is
well conserved between worms and humans.
DISCUSSION
NRF2, as a key antioxidant response regulator, and auto-
phagy, as an important cellular mechanism to eliminate
ROSand reactive nitrogen species, act together topromote
cell survival upon oxidative stress (3, 32, 60). ROS and
oxidative stress/damage alter autophagic flux rates, and
excessive autophagy can promote cell death through the
degradation of important components within the cell (32,
61). However, if oxidative stress is prolonged or already
contained, we showed that it is also NRF2 that acts as a
master regulator to turn off autophagy to avoid the ex-
cessivedestructionof cellular components, andpossibly to
save the cell from autophagic cell death (32). Our results
Figure 7. Oxidative stress decreases the level of autophagy. A) Fluorescent images showing GFP-tagged LGG-1 accumulation in
control animals vs. in animals treated with 1 mM TBHP for 3 h. In one half of the animals, the skn-1 gene expression was depleted
by skn-1 RNAi. GFP::LGG-1 accumulates in punctuate areas that are supposed to indicate autophagosomal structures. B)
Quantification and statistical analysis of fluorescent images of GFP::LGG-1 foci in individual cells. GFP::LGG-1–positive dots that
are believed to correspond to autophagosomal structures were quantified. C) Paralysis assay of worms held on 10 mM final
concentration TBHP plates. Data are expressed as ratio of paralyzed/nonparalyzed worms. skn-1 gene expression was depleted by
skn-1 RNAi. The number of animals examined: n = 40–70. Error bars represent 6 SEM. All experiments were independently
reproduced 3 times. Detailed statistics for each assay can be found in the Supplemental Data. Ns, not significant. *P , 0.05, ***P ,
0.005 (independent 2-sample t tests).
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show that NRF2 binds to both AMPK query and consen-
sus oligonucleotide sequences, suggesting that AMPK can
be directly regulated by NRF2. We predicted and con-
firmed an evolutionary conserved mechanism by which
NRF2 regulates the expression of the autophagy inducer
AMPK, and, by this action, decreases the activation of
autophagy to physiologic levels. We also presented that
theNRF2-mediated autophagy down-regulation can only
be observed upon prolonged stress, highlightingwhy this
excitingmechanismwas not yet discovered. Because both
the function of NRF2 and the regulation of autophagy are
highly complex and context dependent (6, 41, 62), we
cannot excludeother important factors in relation toNRF2,
AMPK, and autophagy. Here, we highlighted a seamless
but effective molecular mechanism for how the antioxi-
dant master regulator NRF2 turns off autophagy when
autophagy has performed its function.
Exploring the regulatory network of NRF2, we pro-
posed a model of a direct transcriptional regulation be-
tween NRF2 and the autophagy regulator AMPK. Many
experimental data have shown that AMPK can stimulate
NRF2 signaling during oxidative agents (e.g., hydrogen
peroxide) (30, 63). The detailed mechanism of this regu-
latory connection, however, is yet unknown. NRF2 pro-
motes autophagy through p62. Because NRF2 knockout
reduces cell viability, we can assume that NRF2 has a
crucial role in promoting autophagy-dependent survival
duringoxidativestress. In thepresent study,weconfirmed
thatNRF2was able to bind theARE binding site atAMPK
(Fig. 3), suggesting that NRF2 directly regulates the ex-
pression of AMPK. We proved this binding by EMSA;
however, this connection needs further confirmation to
showmoredirectproof forNRF2binding toAREelements
(e.g., by using chromatin immunoprecipitation analysis).
We also described that NRF2 is able to down-regulate
AMPK, and this negative effect was manifested at the
transcriptional level during prolonged cellular stress in
both the human cell line andC. elegans (Figs. 2A, B and 6B,
C). By following in time the level ofmain componentswith
respect to TBHP-induced oxidative stress, it turned out
that the timinghas an important role in this network (Figs.
2A, B and 6C, D). Namely, AMPK quickly responds
to oxidative exposure. On the one hand, AMPK becomes
active via phosphorylation; on the other hand, the
AMPKAalpha protein amount is also increased. The
active AMPK can activate NRF2. This regulatory loop
implies that at the very beginning of oxidative stress,
AMPKAalpha protein abundance is independent of NRF2
effects. In addition, this fast response leads to autophagy
induction. The autophagy markers (i.e., LC3-II/LC3-I and
p62) illustrate (Fig. 4B) that autophagy has a transient ac-
tivity change during oxidative stress. LC3-II level was
quickly induced, whereas the p62 level was decreased
whenTBHPwasaddedtoHEK293Tcells.TheLC3-II/LC3-
I level started todecrease,while thep62 level increasedback
after 3 h of oxidative stress. The key autophagy activator
ULK1 has also shown a transient activatory phosphoryla-
tion on its Ser555, further supposing a transient activation
of autophagy. This result seems to fit to microscopy data
when the LC3-II–positive foci were detected upon oxida-
tive stress (Fig. 5). Both data confirm that autophagy has a
delayed down-regulation during permanent TBHP treat-
ment. However, after a certain time delay, NRF2 is able to
down-regulate AMPK. Down-regulation of AMPK results
in the inactivation of its targets (including NRF2). The si-
lenced NRF2 gene results in the continuous up-regulation
of AMPK during extended oxidative stress because the
delayed negative feedback has been diminished from the
control network.
TheC. elegans experiments performedhere have further
uncovered this important regulatory mechanism of auto-
phagy and confirmed the in vitro results. In the present
study,we found that in response tooxidativestress, SKN-1
down-regulates aak-2 in C. elegans as well. Relative to
control animals, aak-2::gfp expression levels were signifi-
cantly increased in animals treatedwith skn-1RNAi. SKN-
1was required to keep aak-2 expression at low levels upon
acute oxidative stress, whereas this effect was not seen
under chronic oxidative stress circumstances. We noted
that SKN-1 down-regulates aak-2 (Fig. 6C, D) not only as
part of the antioxidant response but under normal cir-
cumstances as well. Similarly,.60 genes were previously
describedasbeingdown-regulatedunderbasal conditions
by SKN-1 (64, 65). In the paralysis assay, the aak-2mutant
animals toleratedoxidative stress better than thewild-type
animals. However, this increased stress tolerance seemed
SKN-1 dependent (Fig. 6E). The decreased stress tolerance
of the skn-1 RNAi-treated skn-1 gain-of-function mutant
animals (relative to the control skn-1 mutant animals)
proves that the gene silencing with RNAi worked, and it
was effective. Animals carrying the gain-of-functionmuta-
tion display high stress resistance among. The reason for
the elevated but not significant increase (4 vs. 30%
paralyzed animals) of stress tolerance of the skn-1 gain-
of-function mutant animals (compared with skn-1
RNAi animals) may be a function of the not completely
skn-1 gene-silenced neuronal cells. In these cells, some
SKN-1 protein is constitutively active and can influence
motility despite the RNAi.
Webelieve that thisdelayednegative feedbackbetween
AMPK and its targets plays a significant role in the fine-
tuning of autophagy induction. To further explore the role
of NRF2 in the delayed down-regulation of AMPKduring
oxidative stress in human cell line, we propose a theoret-
ical mathematical model to illustrate and interpret the
important connections and feedback of the NRF2/AMPK
regulatory network (Fig. 8A). According to our experi-
mental data, AMPK has a quick transient activation fol-
lowed by autophagy induction with respect to oxidative
stress (Fig. 8B). After 4 h of treatment with an oxidative
stressor, NRF2-dependent down-regulation of AMPK oc-
curred, controlled by a delayed negative feedback be-
tween AMPK and NRF2. This connection immediately
induces the inactivation of autophagy during prolonged
oxidative stress. A quick activation of autophagy is es-
sential with respect to oxidative stress because the bulk of
damaged components have to be reduced during oxida-
tive stress. Obviously, the extended autophagic event is
not beneficial for thecellular system; therefore, the cell tries
to reduce autophagy to avoid a harmful self-digestion.We
propose that this delayed negative feedback between
AMPK and NRF2 has a main role in guaranteeing that
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autophagy does not become hyperactivated even at
high levels or prolongation of cellular stress. In the
absence of NRF2, the delayed negative feedback
becomes disrupted; therefore, the AMPK levels remain
high even after 4 h of treatment with an oxidative
stressor (Fig. 8C). The high level of AMPK is able to
keep the autophagy processes active. Our results sug-
gest that for the proper cellular stress-dependent acti-
vation of autophagy, both AMPK and NRF2 are
required. At an early stage of the autophagy process,
AMPK is required for autophagy activation, while in
the later phase of the stress event, NRF2 is essential to
down-regulate the process via inhibiting its own acti-
vator. In thisway,with certain delay, NRF2 start down-
regulating AMPK, and therefore, the level of active
autophagy is also dropping. However, in our model,
we did not rule out that NRF2 has a positive effect on
autophagy induction in later phases of oxidative stress.
We believe that NRF2 alone is not sufficient tomaintain
autophagic response when AMPK is diminished.
In healthy cells, stress induces autophagy; however,
above a certain level, autophagy could result in
cell death or may lead to the onset of harmful
processes (1, 32, 66). Thus, we propose that SKN-1 is
supposed to prevent these undesired cellular events.
Elevated levels of autophagy were detected (in an aak-
2–dependent manner) in animals exposed to oxidative
stress when SKN-1 protein was depleted (Fig. 7A, B).
This is not the first known regulatory mechanism
through which SKN-1 controls autophagy. SKN-1
regulates autophagy through binding to the ARE
element in the promoter of p62 gene as well, and p62
in turn delivers polyubiquitinated cargoes to auto-
phagy via the LIR/Atg8 family–interacting domain
(17, 25).
In summary, we established a new role for NRF2 in
regulating the dynamics of autophagy. Upon prolonged
oxidative stress, NRF2 decreases the activation of auto-
phagy through the down-regulation of AMPK to prevent
the harmful hyperactivation of autophagy, and with that,
promote cellular survival. Oxidative stress has been rec-
ognized as a major contributing factor in aging and in
various forms of pathophysiology, including neuro-
degeneration, diabetes, liver diseases, and cancer (67–75).
In the last decade, the role of autophagy in oxidative
stress–related diseases has been reported in detail, show-
ing that normally functioning autophagy can promote
cellular survival, whereas malfunction in autophagy reg-
ulation can lead to cell death and disease phenotypes.
However, the method by which activated autophagy is
turned off when oxidative stress is prolonged or already
contained has not been elaborated, despite several phe-
notypic reports on the existence of such a crosstalk. In the
present study, combining regulatory network analysis
with experimental validation in a model organism, C. ele-
gans, and in a human cell line, we reported the critical role
of NRF2 in inhibiting autophagy hyperactivation upon
prolonged oxidative stress. By unraveling how NRF2/
SKN-1 could regulate autophagy upon prolonged oxida-
tive stress, we highlighted an evolutionary conserved
mechanismthroughwhich cellularmechanisms interact to
promote survival.
Figure 8. Proposed computa-
tional model of NRF2-dependent
AMPK down-regulation during
oxidative stress. A) The core
network of AMPK and NRF2
regulation with respect to oxida-
tive stress. The dotted line de-
notes how the components can
influence each other. B) Numer-
ical simulations of relative pro-
tein levels and activities of the
HEK293T cell line with a math-
ematical model during oxidative
stress. Both AMPK and NRF2
have a transient activation profile
resulting in the down-regulation
of autophagy after 4 h of oxida-
tive stress. C) Numerical simula-
tions of relative protein levels
and activities of the HEK293T +
siNRF2 cell line with a mathe-
matical model during oxidative
stress. The active AMPK is able to
maintain the autophagic process
high in the absence of NRF2.
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sity, and by the ÚNKP-17-4-III-SE-75 New National Excellence
Program of the Ministry of Human Capacities. O.K., A.S., and G.B.
were supported by the National Research, Development and
Innovation Office (K112696, K124813 and K123752). This article
is based upon work from European Cooperation in Science and
Technology (COST) Action (PROTEOSTASIS BM1307). This
work was supported by the the Hungarian Scientific Research
Fund (OTKA; Grant NK78012), the MEDinPROT Protein Science
Research Synergy Program [provided by the Hungarian Academy
of Sciences (MTA)], and the Competitive Central-Hungarian
Operational Program (VEKOP-2.3.2-16-2017-00014). T.V. is sup-
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62. Kubisch, J., Türei,D., Földvári-Nagy, L.,Dunai, Z.A., Zsákai, L., Varga,
M., Vellai, T., Csermely, P., and Korcsmáros, T. (2013) Complex
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